Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study

Abstract

Intrauterine balloon tamponade is effective for achieving haemostasis in intractable postpartum haemorrhages.

Evaluation of the effectiveness of metreurynters for balloon tamponade

“…16,17) This success rate was similar to rates with other treatment methods, including embolization and uterine compression sutures. 18) In addition, the present hemostasis results using small metreurynters are consistent with previous studies showing the effectiveness of Foley balloon catheters for local treatment of CSP and CP.…”

Authors’ reply re: Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study

“…Stigma is a widely recognised issue with HIV within any patient group, but relevant to this study is among women 2 and migrants. 3 The recommendation in this paper's conclusion 1 suggests that all migrant women of unknown HIV status diagnosed with CIN2 + should be tested for HIV. Although this assertion is indeed supported by the results of the study, the greater association between migrant women and HIV, and the singling out of migrant women compared with native Swedes, will likely act to further marginalise and increase the…”

“…1,2 We acknowledge that we cannot rule out a selection bias or possible overestimation of the efficacy of the intrauterine balloon tamponade (IUBT). The indication for the IUBT test was clearly restricted to immediate haemorrhages due to uterine atony or placenta praevia, but the decision to use IUBT was left to the physician's discretion in this pragmatic prospective cohort study.…”

“…Finally, we think that the appropriate question now is not how to identify appropriate patients for IUBT but rather when to use IUBT. Re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study Sir, We read with interest the paper by Carlander et al 1 on the prevalence of undiagnosed HIV in women with cervical intraepithelial neoplasia grade two or worse (CIN2 + ), and whether HIV testing for women diagnosed with CIN2 + would be a cost-effective measure. We commend the authors on their work and results, and congratulate them on achieving another step toward earlier diagnosis in HIV and therefore more positive outcomes for patients.…”

“…The clever use of population-based registers to determine cervical health and HIV status allowed the authors to conduct their study on a large scale, 1 giving their results better statistical power. However, working retrospectively and using registers to estimate HIV status at the time of CIN2 + diagnosis does have its limitations.…”